Table 3.
Apheresis product counts of dogs with T‐ and B‐cell lymphoma using a CaridianBCT cell separator.
| WBCs (Cells/μL) | Plts (Cells/μL) | Grans (%) | Hct (%) | Mono (Cells/μL) | CD34+ (%) | CD34+ (Cells/kg) | MCCE (%) | |
|---|---|---|---|---|---|---|---|---|
| TCLa (n = 14) | ||||||||
| Range | 13,770–357,300 | 92 x 103–1,373 x 103 | 0–45 | 2.1–4.5 | 10,643–110,763 | 1.3–6.7 | 2 x 106–42 x 106 | 3.6–68.8 |
| Mean ± SD | 92,217 ± 87,051 | 725 x 103 ± 403 x 103 | 18.0 ± 16.2 | 5.7 ± 0.7 | 43,846 ± 34,105 | 2.4 ± 1.4 | 1.4 x 107 ± 1.2 x 107 | 36.2 ± 18 |
| BCL10 (n = 16) | ||||||||
| Range | 18,310–313,560 | 85 x 103–2,833 x 103 | 3.0–4.7 | 1.4–6.2 | 4,944–131,695 | 0.2–4.9 | 3.5 x 106–54.5 x 106 | 8.6–76 |
| Mean ± SD | 105,646 ± 91,341 | 1,195 x 103 ± 750 x 103 | 14.8 ± 13.2 | 3.3 ± 1.2 | 59,639 ± 42,036 | 2.4 ± 1.4 | 1.8 x 107 ± 1.4 x 107 | 37.6 ± 19.3 |
| TCL versus BCL aphereses | ||||||||
| P‐value | .6836 | .0422 | .6243 | .4089 | .8369 | .9878 | .3690 | .7643 |
TCL, T‐cell lymphoma; BCL, B‐cell lymphoma; WBC, white blood cells; Plts, platelets; Grans, granulocytes; Hct, hematocrit; Mono, mononuclear cells; MCCE, mononuclear cell collection efficiency.
a
Does not include 1 dog who underwent apheresis using a Baxter‐Fenwal CS‐3000 Plus cell separator.